{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T02:12:15Z","timestamp":1792980735440,"version":"4.5.0"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100018786","name":"Deanship of Scientific Research and Innovation at Al-Zaytoonah University of Jordan","doi-asserted-by":"publisher","award":["12\/08\/2021-2022"],"award-info":[{"award-number":["12\/08\/2021-2022"]}],"id":[{"id":"10.13039\/501100018786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Cardiovascular disease is one of the leading causes of death. Atherosclerosis\ncauses arterial constriction or obstruction, resulting in acute cardiovascular illness. Cholesteryl ester\ntransfer protein (CETP) facilitates reverse cholesterol transport. It supports the transfer of cholesteryl\nester from HDL to LDL and VLDL. Inhibition of CETP by drugs limits cardiovascular disease by\ndecreasing LDL and increasing HDL.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>In this study, fourteen trifluoromethyl substituted benzene sulfonamides 6a-6g and 7a-7g\nwere prepared.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The synthesized molecules were characterized using 1H-NMR, 13C-NMR, IR and HR-MS.\nThey were in vitro tested to estimate their CETP inhibitory activity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In vitro biological evaluation showed that compounds 7d-7f had the highest inhibitory activity\nwith 100% inhibition, while the inhibition observed by compounds 6a-6g, 7a-7c and 7g ranged\nfrom 2%-72% at 10 \u03bcM concentration. It was found that the addition of a fourth aromatic ring\nsignificantly improved the activity, which may be due to the hydrophobic nature of CETP. Also, the\npresence of ortho-chloro, meta-chloro and para-methyl substituents results in high inhibitory activity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The induced fit docking studies revealed that hydrophobic interaction guided ligand\/\nCETP binding interaction in addition to H-bond formation with Q199, R201, and H232. Furthermore,\npharmacophore mapping demonstrated that this series satisfies the functionalities of the current\nCETP inhibitors.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406418666220908164014","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T09:20:21Z","timestamp":1662974421000},"page":"393-404","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Trifluoromethylated Aryl Sulfonamides as Novel CETP Inhibitors:\nSynthesis, Induced Fit Docking, Pharmacophore Mapping and Subsequent\nIn vitro Validation"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7797-8918","authenticated-orcid":true,"given":"Reema Abu","family":"Khalaf","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza Al","family":"Shaiah","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima","family":"Sabbah","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.repc.2018.05.019","volume":"38","author":"Z\u00e3o A.","year":"2019","unstructured":"Z\u00e3o A.; Magalh\u00e3es S.; Santos M.; Frailty in cardiovascular disease: Screening tools. Rev Port Cardiol 2019,38(2),143-148","journal-title":"Rev Port Cardiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biom8030080","volume":"8","author":"Zhu Y.","year":"2018","unstructured":"Zhu Y.; Xian X.; Wang Z.; Bi Y.; Chen Q.; Han X.; Tang D.; Chen R.; Research progress on the relationship between atherosclerosis and inflammation. Biomolecules 2018,8(3),80","journal-title":"Biomolecules"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/iub.2073","volume":"71","author":"Taghizadeh E.","year":"2019","unstructured":"Taghizadeh E.; Esfehani R.J.; Sahebkar A.; Parizadeh S.M.; Rostami D.; Mirinezhad M.; Poursheikhani A.; Mobarhan M.G.; Pasdar A.; Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies. IUBMB Life 2019,71(9),1221-1229","journal-title":"IUBMB Life"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jjcc.2017.07.002","volume":"71","author":"Ogura M.","year":"2018","unstructured":"Ogura M.; PCSK9 inhibition in the management of familial hypercholesterolemia. J Cardiol 2018,71(1),1-7","journal-title":"J Cardiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12944-017-0488-4","volume":"16","author":"Paththinige C.S.","year":"2017","unstructured":"Paththinige C.S.; Sirisena N.D.; Dissanayake V.H.W.; Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review. Lipids Health Dis 2017,16(1),103","journal-title":"Lipids Health Dis"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14000","volume":"75","author":"Jarab A.S.","year":"2021","unstructured":"Jarab A.S.; Alefishat E.A.; Al-Qerem W.; Mukattash T.L.; Al-Hajjeh D.M.; Lipid control and its associated factors among patients with dyslipidaemia in Jordan. Int J Clin Pract 2021,75(5)","journal-title":"Int J Clin Pract"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.addr.2020.08.003","volume":"159","author":"Busatto S.","year":"2020","unstructured":"Busatto S.; Walker S.A.; Grayson W.; Pham A.; Tian M.; Nesto N.; Barklund J.; Wolfram J.; Lipoprotein-based drug delivery. Adv Drug Deliv Rev 2020,159,377-390","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/10715762.2017.1319944","volume":"51","author":"Ahotupa M.","year":"2017","unstructured":"Ahotupa M.; Oxidized lipoprotein lipids and atherosclerosis. Free Radic Res 2017,51(4),439-447","journal-title":"Free Radic Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/ped.14490","volume":"63","author":"Tonouchi R.","year":"2021","unstructured":"Tonouchi R.; Okada T.; Abe Y.; Kazama M.; Kuromori Y.; Yoshino Y.; Iwata F.; Hara M.; Saito E.; Morioka I.; Subclass distribution of low\u2010density lipoprotein triglyceride and the clustering of metabolic syndrome components in Japanese children. Pediatr Int 2021,63(6),664-670","journal-title":"Pediatr Int"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"8985","DOI":"10.3390\/ijms21238985","volume":"21","author":"Stadler J.T.","year":"2020","unstructured":"Stadler J.T.; Marsche G.; Obesity-related changes in high-density lipoprotein metabolism and function. Int J Mol Sci 2020,21(23),8985","journal-title":"Int J Mol Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.coph.2017.04.005","volume":"33","author":"Chang Y.","year":"2017","unstructured":"Chang Y.; Robidoux J.; Dyslipidemia management update. Curr Opin Pharmacol 2017,33,47-55","journal-title":"Curr Opin Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nsmb1197","volume":"14","author":"Qiu X.","year":"2007","unstructured":"Qiu X.; Mistry A.; Ammirati M.J.; Chrunyk B.A.; Clark R.W.; Cong Y.; Culp J.S.; Danley D.E.; Freeman T.B.; Geoghegan K.F.; Griffor M.C.; Hawrylik S.J.; Hayward C.M.; Hensley P.; Hoth L.R.; Karam G.A.; Lira M.E.; Lloyd D.B.; McGrath K.M.; Stutzman-Engwall K.J.; Subashi A.K.; Subashi T.A.; Thompson J.F.; Wang I.K.; Zhao H.; Seddon A.P.; Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules. Nat Struct Mol Biol 2007,14(2),106-113","journal-title":"Nat Struct Mol Biol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/13543776.2018.1439476","volume":"28","author":"Wang X.","year":"2018","unstructured":"Wang X.; Li W.; Hao L.; Xie H.; Hao C.; Liu C.; Li W.; Xiong X.; Zhao D.; The therapeutic potential of CETP inhibitors: A patent review. Expert Opin Ther Pat 2018,28(4),331-340","journal-title":"Expert Opin Ther Pat"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.ejmech.2009.12.070","volume":"45","author":"Abu Khalaf R.","year":"2010","unstructured":"Abu Khalaf R.; Abu Sheikha G.; Bustanji Y.; Taha M.O.; Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration. Eur J Med Chem 2010,45(4),1598-1617","journal-title":"Eur J Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.3390\/molecules15085721","volume":"15","author":"Sheikha G.A.","year":"2010","unstructured":"Sheikha G.A.; Abu Khalaf R.; Melhem A.; Albadawi G.; Design, synthesis, and biological evaluation of benzylamino-methanone based cholesteryl ester transfer protein inhibitors. Molecules 2010,15(8),5721-5733","journal-title":"Molecules"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/1874104501307010039","volume":"7","author":"Khalaf R.A.","year":"2013","unstructured":"Khalaf R.A.; Sheikha G.A.; Al-Sha\u2019er M.; Taha M.; Design, synthesis and biological evaluation of N4-sulfonamido-succinamic, phthalamic, acrylic and benzoyl acetic acid derivatives as potential DPP IV inhibitors. Open Med Chem J 2013,7(1),39-48","journal-title":"Open Med Chem J"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2174\/1570180814666170412122304","volume":"14","author":"Abu Khalaf R.","year":"2017","unstructured":"Abu Khalaf R.; Abd El-Aziz H.; Sabbah D.; Albadawi G.; Abu Sheikha G.; CETP inhibitory activity of chlorobenzyl benzamides: QPLD docking, pharmacophore mapping and synthesis. Lett Drug Des Discov 2017,14(12),1391-1400","journal-title":"Lett Drug Des Discov"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201700204","volume":"350","author":"Abu Khalaf R.","year":"2017","unstructured":"Abu Khalaf R.; Sabbah D.; Al-Shalabi E.; Bishtawi S.; Albadawi G.; Abu Sheikha G.; Synthesis, biological evaluation, and molecular modeling study of substituted benzyl benzamides as CETP inhibitors. Arch Pharm (Weinheim) 2017,350(12)","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=19","author":"Abu Khalaf R.","year":"2020","unstructured":"Abu Khalaf R.; NasrAllah, A.; Jarrar, W.; Sabbah, D. CETP inhibitory oxoacetamideo-benzamide derivatives: Glide docking, pharmacophore mapping, and synthesis. Braz J Pharm Sci 2020","journal-title":"Braz J Pharm Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/1573406412666161104121042","volume":"13","author":"Abu Khalaf R.","year":"2017","unstructured":"Abu Khalaf R.; Al-Rawashdeh S.; Sabbah D.; Abu Sheikha G.; Molecular docking and pharmacophore modeling studies of fluorinated benzamides as potential CETP inhibitors. Med Chem 2017,13(3),239-253","journal-title":"Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2174\/1573406417666210830125431","volume":"18","author":"Khalaf R.A.","year":"2022","unstructured":"Khalaf R.A.; Awad M.; Al-Qirim T.; Sabbah D.; Synthesis and molecular modeling of novel 3,5-bis(trifluoromethyl) benzylamino benzamides as potential CETP inhibitors. Med Chem 2022,18(4),417-426","journal-title":"Med Chem"},{"key":"ref=22","author":"Abu Khalaf R.","year":"2021","unstructured":"Abu Khalaf R.; Asa\u2019ad M.; Synthesis and biological evaluation of aromatic sulfonamides as novel cholesteryl ester transfer protein inhibitors. Master Thesis, Al-Zaytoonah University of Jordan, Amman, Jordan, 2021"},{"key":"ref=23","author":"Abu Khalaf R.","year":"2021","unstructured":"Abu Khalaf R.; Shalluf A.; Diaryl sulfonamides: synthesis, characterization and in vitro biological evaluation as CETP inhibitors. Master Thesis, Al-Zaytoonah University of Jordan, Amman, Jordan, 2021"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"37321","DOI":"10.1074\/jbc.M112.380063","volume":"287","author":"Liu S.","year":"2012","unstructured":"Liu S.; Mistry A.; Reynolds J.M.; Lloyd D.B.; Griffor M.C.; Perry D.A.; Ruggeri R.B.; Clark R.W.; Qiu X.; Crystal structures of cholesteryl ester transfer protein in complex with inhibitors. J Biol Chem 2012,287(44),37321-37329","journal-title":"J Biol Chem"},{"key":"ref=25","first-page":"97204","year":"2021","unstructured":"Schr\u00f6dinger Protein Preparation Wizard, Maestro, Macromodel, QPLD-dock, and Pymol 2021,97204","journal-title":"Protein Preparation Wizard, Maestro, Macromodel, QPLD-dock, and Pymol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"Friesner R.A.","year":"2004","unstructured":"Friesner R.A.; Banks J.L.; Murphy R.B.; Halgren T.A.; Klicic J.J.; Mainz D.T.; Repasky M.P.; Knoll E.H.; Shelley M.; Perry J.K.; Shaw D.E.; Francis P.; Shenkin P.S.; Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004,47(7),1739-1749","journal-title":"J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"Friesner R.A.","year":"2006","unstructured":"Friesner R.A.; Murphy R.B.; Repasky M.P.; Frye L.L.; Greenwood J.R.; Halgren T.A.; Sanschagrin P.C.; Mainz D.T.; Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 2006,49(21),6177-6196","journal-title":"J Med Chem"},{"key":"ref=28","year":"2020","unstructured":"MOE The Molecular Operating Environment 2020","journal-title":"The Molecular Operating Environment"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220908164014","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208696\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220908164014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T11:26:55Z","timestamp":1692185215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208696\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406418666220908164014","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}